Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Bruno Bezerra Lima

Advanced Cardiac Imaging · VUMC

View

Dr. Sara Ersozlu

Advanced Cardiac Imaging · MGH

View

Dr. Christopher Kramer

Advanced Cardiac Imaging · University of Virginia

View

Dr. Filipe Moura

Advanced Cardiac Imaging · Yale College

View

Dr. Robert Hendel

Advanced Cardiac Imaging · Tulane University

View

Dr. Venkatesh Murthy

Advanced Cardiac Imaging · UMHS

View

Dr. Dorairaj Prabhakaran

General Cardiology

View

Dr. Pugazhendhi Vijayaraman

EP · Geisinger

View

Dr. Robert Schaller

EP · HUP

View

Dr. Trey Woods

General Cardiology · Emory Healthcare

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.

    May 8, 2024DOI: 10.1161/cir.0000000000001250Journal ArticleAHA

    Written by: Steve R OmmenCarolyn Y HoIrfan M AsifSeshadri BalajiMichael A BurkeSharlene M DayJoseph A DearaniKelly C EppsLauren EvanovichVictor A FerrariJosé A JoglarSadiya S KhanJeffrey J KimMichelle M KittlesonChayakrit KrittanawongMatthew W MartinezSeema MitalSrihari S NaiduSara SaberiChristopher SemsarianSabrina TimesCynthia Burstein WaldmanPeer Review Committee Members

    Find these authors on Roon

    VF
    Dr. Victor Ferrari
    Advanced Cardiac Imaging · HUP

    Summary

    AIM: The "2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy" provides recommendations to guide clinicians in the management of patients with hypertrophic cardiomyopathy.METHODS: A comprehensive literature search was conducted from September 14, 2022, to November 22, 2022, encompassing studies, reviews, and other evidence on human subjects that were published in English from PubMed, EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. Additional relevant studies, published through May 23, 2023, during the guideline writing process, were also considered by the writing committee and added to the evidence tables, where appropriate.STRUCTURE: Hypertrophic cardiomyopathy remains a common genetic heart disease reported in populations globally. Recommendations from the "2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy" have been updated with new evidence to guide clinicians.
    VFDr. Victor Ferrari

    Dr. Victor Ferrari

    Cardiology · Advanced Cardiac Imaging
    Hospital of the University of Pennsylvania
    victorf